Semaglutide is injected under the skin in the abdomen, upper arm, or thigh
5 WARNINGS AND PRECAUTIONS WARNINGS AND PRECAUTIONS SECTION 6 ADVERSE REACTIONS ADVERSE REACTIONS SECTION The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions ( 5.1 )] Acute Pancreatitis [see Warnings and Precautions ( 5.2 )] Acute Gallbladder Disease [see Warnings and Precautions ( 5.3 )] Hypoglycemia [see Warnings and Precautions ( 5.4 )] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions ( 5.5 )] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions ( 5.6 )] Hypersensitivity Reactions [see Warnings and Precautions ( 5.7 )] Diabetic Retinopathy Complications in Patients with Type 2 Diabetes [see Warnings and Precautions ( 5.8 )] Heart Rate Increase [see Warnings and Precautions ( 5.9 )] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions ( 5.10 )] 7 DRUG INTERACTIONS DRUG INTERACTIONS SECTION 8 USE IN SPECIFIC POPULATIONS USE IN SPECIFIC POPULATIONS SECTION 10 OVERDOSAGE OVERDOSAGE SECTION Overdoses have been reported with other GLP-1 receptor agonists
If that side-effect pattern sounds familiar, our article on managing nausea on GLP-1 can help you think through day-to-day symptom support
Collaborative care between endocrinologists, primary care providers, and other specialists ensures comprehensive management of these complex, interrelated conditions and optimizes both safety and therapeutic outcomes
In the case of GLP-1 medications, this could include adjustments like adding B12 for potential energy support or modifying the formulation to help with nausea management, both of which are common and well-established practices in compounding
